438PSafety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891. (23rd October 2018) - Powderly, J; Cassier, P A; Cervantes, A; Gao, B; Gazzah, A; Italiano, A; Lin, C-C; Luke, J J; Moreno, V; Peltola, K; Rasco, D; Spira, A I; et al.